EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study

Fleur M Keij iD, Stef Schouwenburg, René F Kornelisse, Tim Preijers, Fatima Mir, Pieter Degraeuwe, Leo M Stolk, Arianne van Driel, Sandra Kenter, Jacqueline van der Sluijs, Jojanneke Heidema, Paul C P den Butter und 5 weitere

Clinical Infectious Diseases · 30.11.2023 · 77 (11) · 1595-1603

DOI: 10.1093/cid/ciad432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 27.09.2023. Verfasst von Fleur M Keij und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Division of Neonatology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Amoxicillin, Bacterial Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw, the Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a lack of evidence on oral amoxicillin pharmacokinetics and exposure in neonates with possible serious bacterial infection (pSBI). We aimed to describe amoxicillin disposition following oral and intravenous administration and to provide dosing recommendations for preterm and term neonates treated for pSBI.

Methods

In this pooled-population pharmacokinetic study, 3 datasets were combined for nonlinear mixed-effects modeling. In order to evaluate amoxicillin exposure following oral and intravenous administration, pharmacokinetic profiles for different dosing regimens were simulated with the developed population pharmacokinetic model. A target of 50% time of the free fraction above the minimal inhibitory concentration (MIC) with an MICECOFF of 8 mg/L (to cover gram-negative bacteria such as Escherichia coli) was used.

Results

The cohort consisted of 261 (79 oral, 182 intravenous) neonates with a median (range) gestational age of 35.8 weeks (range, 24.9–42.4) and bodyweight of 2.6 kg (range, 0.5–5). A 1-compartment model with first-order absorption best described amoxicillin pharmacokinetics. Clearance (L/h/kg) in neonates born after 30 weeks’ gestation increased with increasing postnatal age (PNA day 10, 1.25-fold; PNA day 20, 1.43-fold vs PNA day 3). Oral bioavailability was 87%. We found that a twice-daily regimen of 50 mg/kg/day is superior to a 3- or 4-times daily schedule in the first week of life for both oral and intravenous administration.

Conclusions

This pooled population pharmacokinetic description of intravenous and oral amoxicillin in neonates provides age-specific dosing recommendations. We conclude that neonates treated with oral amoxicillin in the first weeks of life reach adequate amoxicillin levels following a twice-daily dosing regimen. Oral amoxicillin therapy could therefore be an adequate, cost-effective, and more patient-friendly alternative for neonates worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinBacterial InfectionsInfant, NewbornHumansInfantGestational AgeInfusions, IntravenousGram-Negative BacteriaAnti-Bacterial Agents

Stichwörter der Autor:innen

absorptionamoxicillinneonatespharmacokinetics

Substanzen

AmoxicillinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Paediatrics, Division of Neonatology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Department of Paediatrics, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
  • Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Rotterdam Clinical Pharmacometrics Group, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Section of Paediatric Infectious Disease, Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Department of Paediatrics, Division of Neonatology, Maastricht University Medical Centre, Maastricht, The Netherlands.

ORCID-Profile: Fleur M Keij

Förderung

  • ZonMw
  • the Netherlands Organization for Health Research and Development
  • Innovatiefonds Zorgverzekeraars
  • Sophia Foundation

Zitieren

APA

Keij, F. M., Schouwenburg, S., Kornelisse, R. F., Preijers, T., Mir, F., Degraeuwe, P., Stolk, L. M., van Driel, A., Kenter, S., van der Sluijs, J., Heidema, J., den Butter, P. C. P., Reiss, I. K. M., Allegaert, K., Tramper-Stranders, G. A., Koch, B. C. P., & Flint, R. B. (2023). Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study. Clinical Infectious Diseases, 77(11), 1595-1603. https://doi.org/10.1093/cid/ciad432

Vancouver

Keij FM, Schouwenburg S, Kornelisse RF, Preijers T, Mir F, Degraeuwe P, et al. Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study. Clinical Infectious Diseases. 2023;77(11):1595-1603. doi:10.1093/cid/ciad432

BibTeX
@article{Keij2023,
  author = {Keij, Fleur M and Schouwenburg, Stef and Kornelisse, René F and Preijers, Tim and Mir, Fatima and Degraeuwe, Pieter and Stolk, Leo M and van Driel, Arianne and Kenter, Sandra and van der Sluijs, Jacqueline and Heidema, Jojanneke and den Butter, Paul C P and Reiss, Irwin K M and Allegaert, Karel and Tramper-Stranders, Gerdien A and Koch, Birgit C P and Flint, Robert B},
  title = {Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {11},
  pages = {1595--1603},
  doi = {10.1093/cid/ciad432}
}
Kostenlos starten →